AEMD

Aethlon Medical, Inc.

2.19 USD

Last updated Dec 4, 07:03 UTC

Yesterday HIGH

$2.19

Yesterday LOW

$1.84

52w HIGH

$8.7

52w LOW

$1.4

EPS

-1.22

PE

-1.80

Next Earnings

Feb 12, 2024

Overview News Government Trades

Aethlon Medical, Inc. stock is up 17.11% since 30 days ago. The next earnings date is Feb 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.62% of the previous 20 December’s closed higher than November.

Aethlon Medical, Inc. focuses on developing products to diagnose and treat life and organ threatening diseases. The company was founded in 1999 and is based in San Diego, California.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Medical Equipment

Headquarters

San Diego, United States Of America

Website

aethlonmedical.com

Benzinga Insights

Thu Jul 6, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Newsdesk

Wed Jun 28, 2023

Aethlon Medical Q4 EPS $(0.11) Up From $(0.25) YoY, Sales $574.25K Up From $13.12K YoY

Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.11) per share. This is a 56 percent increase over losses of $(0.25) per share from the same period last year. The company reported $574.25 thousand in sales
Benzinga Insights

Wed Jun 28, 2023

Earnings Scheduled For June 28, 2023

Companies Reporting Before The Bell • General Mills (NYSE:GIS) is estimated to report quarterly earnings at $1.07 per share on revenue of $5.17 billion.
Happy Mohamed

Wed Jun 21, 2023

Aethlon Medical Announces Investigation Of The Hemopurifier For Use In Organ Transplantation

Research to Confirm the Hemopurifier's Ability to Remove Harmful Viruses and Exosomes From Harvested Organs SAN DIEGO, June 21, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical
Charles Gross

Fri Jun 16, 2023

UK Health Security Agency Said MPox Vaccinations Extended In London Following Recent Spike In Cases

-Reuters
Happy Mohamed

Thu Jun 8, 2023

Watching Aethlon Medical; Zacks Small-Cap Research Sets $5 Price Target

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_06082023_AEMD_Marin.pdf
Benzinga Newsdesk

Tue Jun 6, 2023

2 Cases Of Mpox Detected In Beijing

https://www.globaltimes.cn/page/202306/1292082.shtml
Benzinga Newsdesk

Mon May 22, 2023

Aethlon Medical Receives Ethics Board Approval To Add Second Site To Its Ongoing Clinical Trial Of Its Hemopurifier To Treat Severe COVID-19 In India

Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that it has received Ethics Review
Charles Gross

Fri May 12, 2023

Report of Mpox Cases Rising in Vaccinated People In Chicago, France

https://www.washingtonpost.com/health/2023/05/12/mpox-monkeypox-gay-bisexual-men/
Happy Mohamed

Thu May 11, 2023

World Health Organization Says Mpox Is No Longer A Global Health Emergency

- Reuters